Urinary retention after AdVance™ Sling: A multi-institutional retrospective study.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
01 2021
Historique:
received: 26 08 2020
revised: 24 10 2020
accepted: 19 11 2020
pubmed: 22 12 2020
medline: 12 6 2021
entrez: 21 12 2020
Statut: ppublish

Résumé

To identify risk factors for urinary retention following AdVance™ Sling placement using preoperative urodynamic studies to evaluate bladder contractility. A multi-institutional retrospective review of patients who underwent an AdVance Sling for post-prostatectomy stress urinary incontinence from 2007 to 2019 was performed. Acute urinary retention (AUR) was defined as the complete inability to void or elevated post-void residual (PVR) leading to catheter placement or the initiation of intermittent catheterization at the first void trial postoperatively. Bladder contractility was evaluated based on preoperative urodynamics. Of the 391 patients in this study, 55 (14.1%) experienced AUR, and 6 patients (1.5%) had chronic urinary retention with a median follow-up of 18.1 months. In total, 303 patients (77.5%) underwent preoperative urodynamics, and there was no significant difference between average PdetQmax (26.4 vs. 27.4 cmH Chronic urinary retention after AdVance Sling placement is uncommon and acute retention is generally self-limiting. No demographic or urodynamic factors were predictive of AUR. Patients who developed AUR were more likely to have their void trials within 2 days following AdVance Sling placement versus longer initial catheterization periods, suggesting that a longer duration of postoperative catheterization may reduce the occurrence of AUR.

Identifiants

pubmed: 33348444
doi: 10.1002/nau.24591
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

515-521

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Collado Serra A, Resel Folkersma L, Dominguez-Escrig JL, et al. AdVance/AdVance XP transobturator male slings: preoperative degree of incontinence as predictor of surgical outcome. Urology. 2013;81:1034-1039.
Carlson KV, Nitti VW. Prevention and management of incontinence following radical prostatectomy. Urol Clin North Am. 2001;28:595-612.
Cornel EB, Elzevier HW, Putter H. Can advance transobturator sling suspension cure male urinary postoperative stress incontinence? J Urol. 2010;183:1459-1463.
Bauer R, Mayer M, Solianik I, et al. One-year results of the AdVance Sling. Urology. 2009:181.
Cornu JN, Sèbe P, Ciofu C, et al. The AdVance transobturator male sling for postprostatectomy incontinence: clinical results of a prospective evaluation after a minimum follow-up of 6 months. Eur Urol. 2009;56:923-927.
Bauer RM, Mayer ME, May F, et al. Complications of the AdVance transobturator male sling in the treatment of male stress urinary incontinence. Urology. 2010;75:1494-1498.
Hall M, Polland A, Weissbart S, Mock S, Grafstein N. Prognostic value of postoperative urinary retention after male sling insertion. Can J Urol. 2014;21:7344-7349.
Sandhu JS, Breyer B, Comiter C, et al. Incontinence after prostate treatment: AUA/SUFU guideline. J Urol. 2019;202:369-378.
Gleason DM, Lattimer JK. The pressure-flow study: a method for measuring bladder neck resistance. J Urol. 1962;87:844-852.
Zuckerman JM, Edwards B, Henderson K, Beydoun HA, McCammon KA. Extended outcomes in the treatment of male stress urinary incontinence with a transobturator sling. Urology. 2014;83:939-945.
Rehder P, Haab F, Cornu JN, Gozzi C, Bauer RM. Treatment of postprostatectomy male urinary incontinence with the transobturator retroluminal repositioning sling suspension: 3-year follow-up. Eur Urol. 2012;62:140-145.
Mueller J, Schrader AJ, Schnoeller T, et al. The retrourethral transobturator sling suspension in the treatment of male urinary stress incontinence: results of a single institution experience. ISRN Urol. 2012;2012:304205.
Kretschmer A, Nitti V. Surgical treatment of male postprostatectomy incontinence: current concepts. Eur Urol Focus. 2017;3:364-376.
Collado A, Dominguez-Escrig J, Ortiz Rodriguez IM, Ramirez-Backhaus M, Rodriguez Torreblanca C, Rubio-Briones J. Functional follow-up after Advance® and Advance XP® male sling surgery: assessment of predictive factors. World J Urol. 2019;37:195-200.
Bauer RM, Grabbert MT, Klehr B, et al. 36-month data for the AdVance XP® male sling: results of a prospective multicentre study. BJU Int. 2017;119:626-630.
Papachristos A, Mann S, Talbot K, Moon D. AdVance male urethral sling: medium-term results in an Australian cohort. ANZ J Surg. 2018;88:E178-E182.
Comiter CV. Surgery insight: surgical management of postprostatectomy incontinence-the artificial urinary sphincter and male sling. Nat Clin Pract Urol. 2007;4:615-624.
Giannantoni A, Mearini E, Di Stasi SM, et al. Assessment of bladder and urethral sphincter function before and after radical retropubic prostatectomy. J Urol. 2004;171:1563-1566.
Matsukawa Y, Hattori R, Komatsu T, Funahashi Y, Sassa N, Gotoh M. De novo detrusor underactivity after laparoscopic radical prostatectomy. Int J Urol. 2010;17:643-648.
Elliott CS, Comiter CV. Maximum isometric detrusor pressure to measure bladder strength in men with postprostatectomy incontinence. Urology. 2012;80:1111-1115.
Cornu JN, Batista Da Costa J, Henry N, Peyrat L, Beley S, Haab F. Comparative study of AdVance and AdVanceXP male slings in a tertiary reference center. Eur Urol. 2014;65:502-504.
Hüsch T, Kretschmer A, Thomsen F, et al. The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference? World J Urol. 2018;36:1657-1662.
McIntosh SL, Griffiths CJ, Drinnan MJ, Robson WA, Ramsden PD, Pickard RS. Noninvasive measurement of bladder pressure. Does mechanical interruption of the urinary stream inhibit detrusor contraction? J Urol. 2003;169:1003-1006.
Comiter CV, Dobberfuhl AD. The artificial urinary sphincter and male sling for postprostatectomy incontinence: which patient should get which procedure? Investig Clin Urol. 2016;57:3-13.
Sullivan MP, DuBeau CE, Resnick NM, Cravalho EG, Yalla SV. Continuous occlusion test to determine detrusor contractile performance. J Urol. 1995;154:1834-1840.

Auteurs

Yu Zheng (Y)

Department of Urology, Medical University of South Carolina, Charleston, South Carolina, USA.

Nicholas Major (N)

Department of Urology, Medical University of South Carolina, Charleston, South Carolina, USA.

Hailey Silverii (H)

Department of Urology, Medical University of South Carolina, Charleston, South Carolina, USA.

Goran Rac (G)

Department of Urology, Medical University of South Carolina, Charleston, South Carolina, USA.

Jennifer Rolef (J)

Department of Urology, Medical University of South Carolina, Charleston, South Carolina, USA.

Lauren Rittenberg (L)

Department of Urology, Medical University of South Carolina, Charleston, South Carolina, USA.

Arthur Mourtzinos (A)

Department of Urology, Lahey Health and Medical Center, Burlington, Massachusetts, USA.

Matthew Moynihan (M)

Department of Urology, Lahey Health and Medical Center, Burlington, Massachusetts, USA.

Ouida L Westney (OL)

Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Michael J Metro (MJ)

Department of Urology, Temple University, Philadelphia, Pennsylvania, USA.

Sender Herschorn (S)

Division of Urology, University of Toronto, Toronto, Ontario, USA.

Jennifer Locke (J)

Division of Urology, University of Toronto, Toronto, Ontario, USA.

Sarah Neu (S)

Division of Urology, University of Toronto, Toronto, Ontario, USA.

Ross Rames (R)

Department of Urology, Medical University of South Carolina, Charleston, South Carolina, USA.

Lindsey Cox (L)

Department of Urology, Medical University of South Carolina, Charleston, South Carolina, USA.

Eric Rovner (E)

Department of Urology, Medical University of South Carolina, Charleston, South Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH